Your search returned 3 results.

Results
	1.	Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors: Weissman, Neil J PMID: 27888609 Year: 2017 Citation: Obesity. 25(1):39-44, 2017 Jan Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ DOI: https://dx.doi.org/10.1002/oby.21695 Add to cart (remove)
	2.	Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors: Aroda, Vanita R PMID: 28386990 Year: 2017 Citation: Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C DOI: https://dx.doi.org/10.1111/dom.12961 Add to cart (remove)
	3.	Obesity in adult lymphoma survivors. MedStar authors: Catlett, Joseph Lynce, Filipa Malkovska, Vera Pehlivanova, Marieta PMID: 21888618 Citation: Leukemia & Lymphoma. 53(4):569-74, 2012 Apr. Institution: MedStar Health Research Institute Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Catlett J, Lynce F, Malkovska V, Pehlivanova M DOI: http://dx.doi.org/10.3109/10428194.2011.619606 Add to cart (remove)

Powered by Koha